A new analysis from Express Scripts reveals that value-based programs are keeping costs down while also improving care and outcomes for patients.

Express Scripts has made no bones about its feelings about drug price increases from companies such as Valeant and Turing. And the PBM giant has already taken steps to push back.

In addition to the two new platform offerings, Express Scripts said it plans to launch other programs that aim to boost transparency around drug pricing and the models it uses to manage costs. For ...

Inside Rx, a new discount program spearheaded by Express Scripts, aims to lower out-of-pocket drug costs for patients, reports CBS News.

Cigna’s (CI) Express Scripts is offering a new prescription drug program that limits costs to consumers, acting as a safety net for millions of newly uninsured individuals.

Express Scripts released several new solutions last week that aim to improve drug price transparency, including a cap on out-of-pocket costs for prescription drugs for consumers. The news comes ...

Express Scripts also is providing data analytics as part of Missouri's new prescription drug-monitoring program. Republican Gov. Eric Greitens announced details last month at the Express Scripts ...

KAISERSLAUTERN, Germany — People receiving prescription drugs through the military mail-order program should check to see if they need to obtain a new prescription because of an upcoming ...

Express Scripts is capping the out-of-pocket cost for 30-day supplies of generic and brand-name prescriptions at $25 and $75, respectively, via its Parachute Rx program to help patients who are ...

Express Scripts is trimming some of its ties to a $35,000-a-vial medicine made by Mallinckrodt, selling a unit that helps patients access some high-priced drugs.

Through the program, Express Scripts guarantees per-patient spending caps, which will lead to participating plans experiencing an average increase in diabetes drug spend in 2017.

Express Scripts also is providing data analytics as part of Missouri’s new prescription drug-monitoring program.